The gene set enrichment analysis (GSEA) based on the data from TCGA database indicated that PCK2 was highly correlated with cellular response to drug, drug metabolic process and drug transport in RCC (Figure 4A). The gene discussed is PCK2; the disease is renal cell carcinoma.